Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2660 (LINC02660)

Target
LINC02660
Molecular classification
Long non-coding RNA, Long intergenic non-protein coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2660 (LINC02660) encodes a long non-coding RNA (lncRNA) and belongs to the family of long intergenic non-protein coding RNAs, commonly abbreviated lincRNAs. LincRNAs are a subclass of non-coding RNAs that act in gene regulation, chromatin remodeling, or RNA stabilization, but most remain poorly characterized. According to public genomic databases, LINC02660 is autonomously transcribed, does not overlap annotated coding genes, and lacks a known protein product. No functional, disease, or clinical associations have been described for LINC02660 in the available scientific literature. This distinguishes LINC02660 from other lincRNAs—such as LINC00665—which have been linked to cancer and other diseases. As such, LINC02660 is currently an obscure and unstudied lincRNA with no established role as a therapeutic target, biomarker, or disease-associated RNA. LINC02660 (Long intergenic non-protein coding RNA 2660) is a lincRNA gene with no documented function, disease association, or drug interactions; it serves as an example of the many poorly characterized non-coding RNA loci in the human genome.

Other names
LINC02660LOC105376367Long intergenic non-protein coding RNA 2660
02

Mechanism of action

None known; no mechanisms of action for drugs targeting this RNA have been described

03

Biological functions

Unknown
04

Disease associations

Unknown
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2660 (LINC02660).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2660 (LINC02660).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call